Industry News

The United Kingdom's Medical Research Council is planning to build the £75 million London Institute of Medical Sciences. Designed by Hawkins\Brown, the 110,000-sf project will provide collaborative biomedical research facilities including two CL-2 biocontainment labs, vibration-mitigated imaging suites, core biotechnology labs, write-up areas, and a data center. The nine-story facility is being created in partnership with Imperial College London and will accommodate up to 45 research groups currently dispersed around Hammersmith Hospital.

Exact Sciences broke ground in August of 2018 on its new corporate headquarters in Madison, Wis. Located in the University Research Park developed by UW Madison, the five-story, 138,000-sf Innovation One facility will be fully leased by Exact Sciences. The $60 million project was designed by Valerio Dewalt Train Associates and is being built by general contractor Findorff.

Texas Tech University is planning to build a $90 million facility for the School of Veterinary Medicine in Amarillo. Located at the Texas Tech Health Sciences Center, the two-building complex will include a clinical skills training center for large animal procedures. The school will accommodate 60 students per year for a total enrollment of 240 for the four-year program, as well as serving up to 200 graduate students who are not seeking a doctorate in veterinary medicine. Construction could begin as early as fall of 2019 with completion in fall of 2021.

Simon Fraser University is constructing the Sustainable Energy and Environmental Engineering Program (SE3P) building in Surrey, British Columbia. Designed by Revery Architecture with Research Facilities Design as laboratory design consultant, the CAD$116 million fast-track project is being constructed with 330 precast concrete architectural components supplied by Surespan Structures.

Moderna Therapeutics opened a $110 million pharmaceutical manufacturing plant in July of 2018 in Norwood, Mass. Supporting phase one and two clinical development programs, the 200,000-sf facility will provide cGMP production and testing facilities for mRNA drug candidates, as well as housing a Personalized Cancer Vaccine (PCV) unit. Featuring sophisticated digital technologies for the integration of manufacturing operations, the building also houses quality control labs, plasmid production suites, preclinical labs, offices, and logistics space.